Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 215.7 million compared to CNY 160.92 million a year ago. Net income was CNY 49.82 million compared to CNY 35.07 million a year ago.

Basic earnings per share from continuing operations was CNY 0.46 compared to CNY 0.32 a year ago. Diluted earnings per share from continuing operations was CNY 0.46 compared to CNY 0.32 a year ago.